Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2008

Open Access 01-12-2008 | Research article

Surfactant proteins SP-B and SP-C and their precursors in bronchoalveolar lavages from children with acute and chronic inflammatory airway disease

Authors: Oliver Tafel, Philipp Latzin, Karl Paul, Tobias Winter, Markus Woischnik, Matthias Griese

Published in: BMC Pulmonary Medicine | Issue 1/2008

Login to get access

Abstract

Background

The surfactant proteins B (SP-B) and C (SP-C) are important for the stability and function of the alveolar surfactant film. Their involvement and down-regulation in inflammatory processes has recently been proposed, but their level during neutrophilic human airway diseases are not yet known.

Methods

We used 1D-electrophoresis and Western blotting to determine the concentrations and molecular forms of SP-B and SP-C in bronchoalveolar lavage (BAL) fluid of children with different inflammatory airway diseases. 21 children with cystic fibrosis, 15 with chronic bronchitis and 14 with pneumonia were included and compared to 14 healthy control children.

Results

SP-B was detected in BAL of all 64 patients, whereas SP-C was found in BAL of all but 3 children; those three BAL fluids had more than 80% neutrophils, and in two patients, who were re-lavaged later, SP-C was then present and the neutrophil count was lower. SP-B was mainly present as a dimer, SP-C as a monomer. For both qualitative and quantitative measures of SP-C and SP-B, no significant differences were observed between the four evaluated patient groups.

Conclusion

Concentration or molecular form of SP-B and SP-C is not altered in BAL of children with different acute and chronic inflammatory lung diseases. We conclude that there is no down-regulation of SP-B and SP-C at the protein level in inflammatory processes of neutrophilic airway disease.
Appendix
Available only for authorised users
Literature
1.
go back to reference Mulugeta S, Beers MF: Surfactant protein C: its unique properties and emerging immunomodulatory role in the lung. Microbes Infect. 2006, 8: 2317-2323. 10.1016/j.micinf.2006.04.009.CrossRefPubMed Mulugeta S, Beers MF: Surfactant protein C: its unique properties and emerging immunomodulatory role in the lung. Microbes Infect. 2006, 8: 2317-2323. 10.1016/j.micinf.2006.04.009.CrossRefPubMed
2.
go back to reference Griese M: Pulmonary surfactant in health and human lung diseases: state of the art. Eur Respir J. 1999, 13: 1455-1476. 10.1183/09031936.99.13614779.CrossRefPubMed Griese M: Pulmonary surfactant in health and human lung diseases: state of the art. Eur Respir J. 1999, 13: 1455-1476. 10.1183/09031936.99.13614779.CrossRefPubMed
3.
go back to reference Perez-Gil J: Molecular interactions in pulmonary surfactant films. BiolNeonate. 2002, 81 (Suppl 1): 6-15. Perez-Gil J: Molecular interactions in pulmonary surfactant films. BiolNeonate. 2002, 81 (Suppl 1): 6-15.
4.
go back to reference Whitsett JA, Weaver TE: Hydrophobic surfactant proteins in lung function and disease. N Engl J Med. 2002, 347: 2141-2148. 10.1056/NEJMra022387.CrossRefPubMed Whitsett JA, Weaver TE: Hydrophobic surfactant proteins in lung function and disease. N Engl J Med. 2002, 347: 2141-2148. 10.1056/NEJMra022387.CrossRefPubMed
5.
go back to reference Weaver TE, Conkright JJ: Functions of Surfactant Proteins B and C. Annu Rev Physiol. 2001, 63: 555-578. 10.1146/annurev.physiol.63.1.555.CrossRefPubMed Weaver TE, Conkright JJ: Functions of Surfactant Proteins B and C. Annu Rev Physiol. 2001, 63: 555-578. 10.1146/annurev.physiol.63.1.555.CrossRefPubMed
6.
go back to reference Hawgood S: Surfactant protein B: structure and function. BiolNeonate. 2004, 85 (4): 285-289. Hawgood S: Surfactant protein B: structure and function. BiolNeonate. 2004, 85 (4): 285-289.
7.
go back to reference Tokieda K, Ikegami M, Wert SE, Baatz JE, Zou Y, Whitsett JA: Surfactant protein B corrects oxygen-induced pulmonary dysfunction in heterozygous surfactant protein B-deficient mice. Pediatr Res. 1999, 46: 708-714. 10.1203/00006450-199912000-00012.CrossRefPubMed Tokieda K, Ikegami M, Wert SE, Baatz JE, Zou Y, Whitsett JA: Surfactant protein B corrects oxygen-induced pulmonary dysfunction in heterozygous surfactant protein B-deficient mice. Pediatr Res. 1999, 46: 708-714. 10.1203/00006450-199912000-00012.CrossRefPubMed
8.
go back to reference Miles PR, Bowman L, Rao KM, Baatz JE, Huffman L: Pulmonary surfactant inhibits LPS-induced nitric oxide production by alveolar macrophages. Am J Physiol. 1999, 276: L186-196.PubMed Miles PR, Bowman L, Rao KM, Baatz JE, Huffman L: Pulmonary surfactant inhibits LPS-induced nitric oxide production by alveolar macrophages. Am J Physiol. 1999, 276: L186-196.PubMed
9.
go back to reference Ryan MA, Akinbi HT, Serrano AG, Perez-Gil J, Wu H, McCormack FX, Weaver TE: Antimicrobial activity of native and synthetic surfactant protein B peptides. J Immunol. 2006, 176: 416-425.CrossRefPubMed Ryan MA, Akinbi HT, Serrano AG, Perez-Gil J, Wu H, McCormack FX, Weaver TE: Antimicrobial activity of native and synthetic surfactant protein B peptides. J Immunol. 2006, 176: 416-425.CrossRefPubMed
10.
go back to reference Griese M, Schumacher S, Tredano M, Steinecker M, Braun A, Guttentag S, Beers MF, Bahuau M: Expression profiles of hydrophobic surfactant proteins in children with diffuse chronic lung disease. Respiratory Reasearch. 2005, 6: 80-10.1186/1465-9921-6-80. Griese M, Schumacher S, Tredano M, Steinecker M, Braun A, Guttentag S, Beers MF, Bahuau M: Expression profiles of hydrophobic surfactant proteins in children with diffuse chronic lung disease. Respiratory Reasearch. 2005, 6: 80-10.1186/1465-9921-6-80.
11.
go back to reference Günther A, Siebert C, Schmidt R, Ziegler S, Grimminger F, Yabut M, Temmesfeld B, Walmrath D, Morr H, Seeger W: Surfactant alterations in severe pneumonia, acute respiratory distress syndrome and cardiogenic lung edema. Am J Respir Crit Care Med. 1996, 153: 176-184.CrossRefPubMed Günther A, Siebert C, Schmidt R, Ziegler S, Grimminger F, Yabut M, Temmesfeld B, Walmrath D, Morr H, Seeger W: Surfactant alterations in severe pneumonia, acute respiratory distress syndrome and cardiogenic lung edema. Am J Respir Crit Care Med. 1996, 153: 176-184.CrossRefPubMed
12.
go back to reference LeVine AM, Lotze A, Stanley S, Stroud C, O'Donnell R, Whitsett JA, Pollack MM: Surfactant content in children with inflammatory lung disease. Crit Care Med. 1996, 24: 1062-1067. 10.1097/00003246-199606000-00029.CrossRefPubMed LeVine AM, Lotze A, Stanley S, Stroud C, O'Donnell R, Whitsett JA, Pollack MM: Surfactant content in children with inflammatory lung disease. Crit Care Med. 1996, 24: 1062-1067. 10.1097/00003246-199606000-00029.CrossRefPubMed
13.
go back to reference Griese M, Birrer P, Demirsoy A: Pulmonary surfactant in cystic fibrosis. Eur Respir J. 1997, 10: 1983-1988. 10.1183/09031936.97.10091983.CrossRefPubMed Griese M, Birrer P, Demirsoy A: Pulmonary surfactant in cystic fibrosis. Eur Respir J. 1997, 10: 1983-1988. 10.1183/09031936.97.10091983.CrossRefPubMed
14.
go back to reference Griese M, Essl R, Schmidt R, Rietschel E, Ratjen F, Ballmann M, Paul K: Pulmonary Surfactant, Lung Function and Endobronchial Inflammation in Cystic Fibrosis. Am J Respir Crit Care Med. 2004, 170: 1000-1005. 10.1164/rccm.200405-575OC.CrossRefPubMed Griese M, Essl R, Schmidt R, Rietschel E, Ratjen F, Ballmann M, Paul K: Pulmonary Surfactant, Lung Function and Endobronchial Inflammation in Cystic Fibrosis. Am J Respir Crit Care Med. 2004, 170: 1000-1005. 10.1164/rccm.200405-575OC.CrossRefPubMed
15.
go back to reference Hull J, South M, Phelan P, Grimwood K: Surfactant composition in infants and young children with cystic fibrosis. Am J Respir Crit Care Med. 1997, 156: 161-165.CrossRefPubMed Hull J, South M, Phelan P, Grimwood K: Surfactant composition in infants and young children with cystic fibrosis. Am J Respir Crit Care Med. 1997, 156: 161-165.CrossRefPubMed
16.
go back to reference Schmidt R, Markart P, Ruppert C, Temmesfeld B, Nass R, Lohmeyer J, Seeger W, Gunther A: Pulmonary surfactant in patients with Pneumocystis pneumonia and acquired immunodeficiency syndrome. Crit Care Med. 2006, 34: 2370-2376. 10.1097/01.CCM.0000234036.19145.52.CrossRefPubMed Schmidt R, Markart P, Ruppert C, Temmesfeld B, Nass R, Lohmeyer J, Seeger W, Gunther A: Pulmonary surfactant in patients with Pneumocystis pneumonia and acquired immunodeficiency syndrome. Crit Care Med. 2006, 34: 2370-2376. 10.1097/01.CCM.0000234036.19145.52.CrossRefPubMed
17.
go back to reference Greene KE, Wright JR, Steinberg KP, Ruzinski JT, Caldwell E, Wong WB, Hull W, Whitsett JA, Akino T, Kuroki J, Nagae H, Hudson LD, Martin TR: Serial changes in surfactant-associated proteins in lung and serum before and after onset of ARDS. Am J Respir Crit Care Med. 1999, 160: 1843-1850.CrossRefPubMed Greene KE, Wright JR, Steinberg KP, Ruzinski JT, Caldwell E, Wong WB, Hull W, Whitsett JA, Akino T, Kuroki J, Nagae H, Hudson LD, Martin TR: Serial changes in surfactant-associated proteins in lung and serum before and after onset of ARDS. Am J Respir Crit Care Med. 1999, 160: 1843-1850.CrossRefPubMed
18.
go back to reference Kerr MH, Paton JY: Surfactant protein levels in severe respiratory syncytial virus infection. Am J Resp Crit Care Med. 1999, 159: 1115-1118.CrossRefPubMed Kerr MH, Paton JY: Surfactant protein levels in severe respiratory syncytial virus infection. Am J Resp Crit Care Med. 1999, 159: 1115-1118.CrossRefPubMed
19.
go back to reference Ten Brinke A, Lambert MG, van Golde LG, Batenburg JJ: Palmitoylation and processing of the lipopeptide surfactant protein C. Biochim Biophys Acta. 2002, 1583: 253-265.CrossRefPubMed Ten Brinke A, Lambert MG, van Golde LG, Batenburg JJ: Palmitoylation and processing of the lipopeptide surfactant protein C. Biochim Biophys Acta. 2002, 1583: 253-265.CrossRefPubMed
20.
go back to reference Oosterlaken-Dijksterhuis MA, Haagsman HP, van Golde LM, Demel RA: Characterization of lipid insertion into monomolecular layers mediated by lung surfactant proteins SP-B and SP-C. Biochemistry. 1991, 30: 10965-10971. 10.1021/bi00109a022.CrossRefPubMed Oosterlaken-Dijksterhuis MA, Haagsman HP, van Golde LM, Demel RA: Characterization of lipid insertion into monomolecular layers mediated by lung surfactant proteins SP-B and SP-C. Biochemistry. 1991, 30: 10965-10971. 10.1021/bi00109a022.CrossRefPubMed
21.
go back to reference Qanbar R, Cheng S, Possmayer F, Schurch S: Role of the palmitoylation of surfactant-associated protein C in surfactant film formation and stability. Am J Physiol. 1996, 271: L572-L580.PubMed Qanbar R, Cheng S, Possmayer F, Schurch S: Role of the palmitoylation of surfactant-associated protein C in surfactant film formation and stability. Am J Physiol. 1996, 271: L572-L580.PubMed
22.
go back to reference Augusto LA, Li J, Synguelakis M, Johansson J, Chaby R: Structural basis for interactions between lung surfactant protein C and bacterial lipopolysaccharide. J Biol Chem. 2002, 277: 23484-23492. 10.1074/jbc.M111925200.CrossRefPubMed Augusto LA, Li J, Synguelakis M, Johansson J, Chaby R: Structural basis for interactions between lung surfactant protein C and bacterial lipopolysaccharide. J Biol Chem. 2002, 277: 23484-23492. 10.1074/jbc.M111925200.CrossRefPubMed
23.
go back to reference Augusto LA, Synguelakis M, Johansson J, Pedron T, Girard R, Chaby R: Interaction of pulmonary surfactant protein C with CD 14 and lipopolysaccharide. Infect Immun. 2003, 71: 61-67. 10.1128/IAI.71.1.61-67.2003.CrossRefPubMedPubMedCentral Augusto LA, Synguelakis M, Johansson J, Pedron T, Girard R, Chaby R: Interaction of pulmonary surfactant protein C with CD 14 and lipopolysaccharide. Infect Immun. 2003, 71: 61-67. 10.1128/IAI.71.1.61-67.2003.CrossRefPubMedPubMedCentral
24.
go back to reference Griese M, Neumann M, von Bredow T, Schmidt R, Ratjen F: Surfactant in children with malignancies, immunosuppression, fever and pulmonary infiltrates. Eur Respir J. 2002, 20: 1284-1291. 10.1183/09031936.02.00205702.CrossRefPubMed Griese M, Neumann M, von Bredow T, Schmidt R, Ratjen F: Surfactant in children with malignancies, immunosuppression, fever and pulmonary infiltrates. Eur Respir J. 2002, 20: 1284-1291. 10.1183/09031936.02.00205702.CrossRefPubMed
25.
go back to reference Paul K, Rietschel E, Ballmann M, Griese M, Worlitzsch D, Shute J, Chen C, Schink T, Doring G, van Koningsbruggen S, Wahn U, Ratjen F: Effect of treatment with dornase alpha on airway inflammation in patients with cystic fibrosis. Am J Respir Crit Care Med. 2004, 169: 719-725. 10.1164/rccm.200307-959OC.CrossRefPubMed Paul K, Rietschel E, Ballmann M, Griese M, Worlitzsch D, Shute J, Chen C, Schink T, Doring G, van Koningsbruggen S, Wahn U, Ratjen F: Effect of treatment with dornase alpha on airway inflammation in patients with cystic fibrosis. Am J Respir Crit Care Med. 2004, 169: 719-725. 10.1164/rccm.200307-959OC.CrossRefPubMed
26.
go back to reference Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976, 72: 248-254. 10.1016/0003-2697(76)90527-3.CrossRefPubMed Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976, 72: 248-254. 10.1016/0003-2697(76)90527-3.CrossRefPubMed
27.
go back to reference Gustafsson M, Curstedt T, Jörnvall H, Johansson J: Reverse-phase HPLC of the hydrophobic pulmonary surfactant proteins: detection of a surfactant protein C isoform containing Nε-palmitoyl-lysine. Biochem J. 1976, 326: 799-806.CrossRef Gustafsson M, Curstedt T, Jörnvall H, Johansson J: Reverse-phase HPLC of the hydrophobic pulmonary surfactant proteins: detection of a surfactant protein C isoform containing Nε-palmitoyl-lysine. Biochem J. 1976, 326: 799-806.CrossRef
28.
go back to reference Johansson J: Structure and properties of surfactant protein C. Biochim Biophys Acta. 1998, 1408: 161-172.CrossRefPubMed Johansson J: Structure and properties of surfactant protein C. Biochim Biophys Acta. 1998, 1408: 161-172.CrossRefPubMed
Metadata
Title
Surfactant proteins SP-B and SP-C and their precursors in bronchoalveolar lavages from children with acute and chronic inflammatory airway disease
Authors
Oliver Tafel
Philipp Latzin
Karl Paul
Tobias Winter
Markus Woischnik
Matthias Griese
Publication date
01-12-2008
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2008
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/1471-2466-8-6

Other articles of this Issue 1/2008

BMC Pulmonary Medicine 1/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.